Healthcare provider profile · identity verified

Jill M Barry, MD

Internal Medicine · LANSING, MI · NPI 1285629238

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1070	364
Amlodipine Besylate	Amlodipine Besylate	672	233
Albuterol Sulfate Hfa	Albuterol Sulfate	500	155
Lisinopril	Lisinopril	429	133
Losartan Potassium	Losartan Potassium	402	130
Metformin Hcl	Metformin Hcl	278	90
Hydrochlorothiazide	Hydrochlorothiazide	272	110
Carvedilol	Carvedilol	254	82
Metoprolol Succinate	Metoprolol Succinate	172	61
Pantoprazole Sodium	Pantoprazole Sodium	152	60
Rosuvastatin Calcium	Rosuvastatin Calcium	150	42
Omeprazole	Omeprazole	139	56
Metoprolol Tartrate	Metoprolol Tartrate	132	45
Ozempic	Semaglutide	124	30
Clopidogrel	Clopidogrel Bisulfate	121	40
Chlorthalidone	Chlorthalidone	103	31
Donepezil Hcl	Donepezil Hcl	102	41
Furosemide	Furosemide	98	35
Levothyroxine Sodium	Levothyroxine Sodium	98	40
Jardiance	Empagliflozin	97	22
Tamsulosin Hcl	Tamsulosin Hcl	90	43
Nifedipine Er	Nifedipine	85	25
Hydralazine Hcl	Hydralazine Hcl	81	31
Simvastatin	Simvastatin	81	31
Alendronate Sodium	Alendronate Sodium	79	24
Glipizide	Glipizide	78	24
Potassium Chloride	Potassium Chloride	78	29
Eliquis	Apixaban	76	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	29
Fluticasone Propionate	Fluticasone Propionate	73	29
Januvia	Sitagliptin Phosphate	72	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	26
Sertraline Hcl	Sertraline Hcl	70	36
Alcohol Prep Pads	Alcohol Antiseptic Pads	63	13
Diclofenac Sodium	Diclofenac Sodium	63	25
Isosorbide Mononitrate Er	Isosorbide Mononitrate	63	24
Allopurinol	Allopurinol	62	23
Pravastatin Sodium	Pravastatin Sodium	58	20
Azithromycin	Azithromycin	55	51
Montelukast Sodium	Montelukast Sodium	54	19
Trazodone Hcl	Trazodone Hcl	53	23
Duloxetine Hcl	Duloxetine Hcl	50	21
Methylprednisolone	Methylprednisolone	47	40
Ibuprofen	Ibuprofen	46	17
Breo Ellipta	Fluticasone/Vilanterol	44	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	17
Clonidine Hcl	Clonidine Hcl	43	15
Famotidine	Famotidine	41	18
Mirtazapine	Mirtazapine	41	18
Gabapentin	Gabapentin	40	30
Spironolactone	Spironolactone	38	16
Ventolin Hfa	Albuterol Sulfate	38	14
Atenolol	Atenolol	36	11
Nitroglycerin	Nitroglycerin	36	13
Novolog Flexpen	Insulin Aspart	36	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	35	33
Ezetimibe	Ezetimibe	34	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	33	13
Symbicort	Budesonide/Formoterol Fumarate	33	17
Glipizide Er	Glipizide	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	13
Naproxen	Naproxen	30	13
Finasteride	Finasteride	29	suppressed
Metformin Hcl Er	Metformin Hcl	29	13
Bumetanide	Bumetanide	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	11
Advair Hfa	Fluticasone Propion/Salmeterol	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	14
Alcohol Swabs	Alcohol Antiseptic Pads	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	11
Buspirone Hcl	Buspirone Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Linzess	Linaclotide	17	suppressed
Risedronate Sodium	Risedronate Sodium	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Dilt-Xr	Diltiazem Hcl	15	suppressed
Fluconazole	Fluconazole	15	13
Memantine Hcl	Memantine Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Baclofen	Baclofen	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Cephalexin	Cephalexin	12	11
Entresto	Sacubitril/Valsartan	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	11	11
Lacosamide	Lacosamide	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Single Use Swab	Alcohol Antiseptic Pads	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error